Chad vs Senegal: Treatment coverage for schistosomiasis
Chad
38.0%
in 2024
Senegal
39.7%
in 2024
Chad rank
32nd
Senegal rank
29th
Treatment coverage for schistosomiasis over time
- Chad
- Senegal
How they compare
Senegal currently reports 39.7% against 38.0% in Chad, a difference of 1.7%.
The two have swapped places 3 times across 7 shared years of data; in 2017 it was Chad ahead.
Chad ranks 32nd and Senegal ranks 29th of 45 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Chad | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 47.6% | 39.3% | 8.3% | Chad |
| 2020s | 35.7% | 42.9% | 7.3% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Chad or Senegal?
- Senegal, at 39.7% against 38.0% in Chad as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Chad and Senegal?
- 1.7%, with Senegal ahead.
- How many years of comparable data are there for Chad and Senegal?
- 7 years are reported by both, from 2017 to 2024.
- How do Chad and Senegal rank globally for treatment coverage for schistosomiasis?
- Chad ranks 32nd and Senegal ranks 29th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.